|
LegalView Reports Development of a Breakthrough Study Explaining How Asbestos Causes Mesothelioma Cancer (PRWeb)
LegalView recently reported of a study by scientists at Ohio State University who are attempting to determine the molecular details of how asbestos fibers bind to human cancer cells. The scientists hope that with the study, they will eventually be able to produce more adequate mesothelioma treatments. (PRWeb Dec 31, 2008) Read the full story at ...
us.rd.yahoo.com
LegalView Reports Development of a Breakthrough Study Explaining How Asbestos Causes Mesothelioma Cancer (PRWeb via Yahoo! News)
LegalView recently reported of a study by scientists at Ohio State University who are attempting to determine the molecular details of how asbestos fibers bind to human cancer cells. The scientists hope that with the study, they will eventually be able to produce more adequate mesothelioma treatments.
us.rd.yahoo.com
Innovative Mesothelioma Video Library Wins Web Awards While Educating Viewers (Medical News Today)
The SimmonsCooper law firm announced today that the Mesothelioma Video Library Web site, a free educational resource for patients and families affected by mesothelioma, has been recognized by the Web Marketing Association and W3 Awards for its innovation and excellence on the web. The Mesothelioma Video Library is the first video-driven Web site to address mesothelioma and asbestos-related issues.
us.rd.yahoo.com
LegalView Features New Traumatic Brain Injury Treatment Information For U.S. Soldiers Using Diver's Therapy for Victims (PRWeb)
LegalView recently updated its traumatic brain injury information portal with a potential new treatment that is being examined by researchers and may assist U.S. soldiers suffering from brain injury. The treatment is often used on a condition known as diver's bends, but may be useful among TBI patients. (PRWeb Dec 31, 2008) Read the full story at ...
us.rd.yahoo.com
LegalView Features New Traumatic Brain Injury Treatment Information For U.S. Soldiers Using Diver's Therapy for Victims (PRWeb via Yahoo! News)
LegalView recently updated its traumatic brain injury information portal with a potential new treatment that is being examined by researchers and may assist U.S. soldiers suffering from brain injury. The treatment is often used on a condition known as diver's bends, but may be useful among TBI patients.
us.rd.yahoo.com
Innovative Mesothelioma Video Library Wins Web Awards While Educating Viewers (PRWeb)
The Mesothelioma Video Library, a free online resource dedicated to educating and engaging viewers about mesothelioma, a rare cancer caused by exposure to asbestos, receives international recognition. (PRWeb Dec 22, 2008) Read the full story at http://www.prweb.com/releases/2008mesothelioma/12videos/prweb1776404.htm
us.rd.yahoo.com
Innovative Mesothelioma Video Library Wins Web Awards While Educating Viewers (PRWeb via Yahoo! News)
The Mesothelioma Video Library, a free online resource dedicated to educating and engaging viewers about mesothelioma, a rare cancer caused by exposure to asbestos, receives international recognition.
us.rd.yahoo.com
Belluck & Fox Announces that Partners and Mesothelioma Attorneys Joseph W. Belluck and Jordan Fox Listed Among the Top ... (PRWeb)
Belluck & Fox is proud to announce that partners Joseph W. Belluck and Jordan Fox have been listed among the top mass tort attorneys in the New York Area. (PRWeb Dec 25, 2008) Read the full story at http://www.prweb.com/releases/2008/12/prweb1788874.htm
us.rd.yahoo.com
Belluck & Fox Announces that Partners and Mesothelioma Attorneys Joseph W. Belluck and Jordan Fox Listed Among the Top ... (PRWeb via Yahoo! News)
Belluck & Fox is proud to announce that partners Joseph W. Belluck and Jordan Fox have been listed among the top mass tort attorneys in the New York Area.
us.rd.yahoo.com
LegalView Reports FDA Delay of Drug That Might Prevent OxyContin Drug Abuse (PR.com)
LegalView informed readers of a new drug that would likely replace OxyContin and prevent the abuse commonly associated with consuming a prescription pain medication. The FDA has delayed the release of the drug requesting more information on it, but no additional clinical trials. [PR.com - December 26, 2008]
us.rd.yahoo.com
|
